All Medical Microbiology articles
-
NewsWebinar: Unraveling periprosthetic joint infection
The free ‘Unraveling Periprosthetic Joint Infection’ webinar on March 25 explores one of the most challenging complications in modern orthopedic medicine, sitting at the intersection of microbiology, surgery, and patient care.
-
NewsDengue vaccine remains 80.5% effective against severe cases after five years
The tetravalent dengue vaccine was 80.5% effective against severe dengue cases with warning signs over a five-year period. Overall, the vaccine was 65% effective in preventing symptomatic dengue (caused by any serotype) during the five years of monitoring.
-
News Thermo Fisher Scientific launches new color-based culture media to help detect Candida infections faster
Thermo Fisher Scientific today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species.
-
NewsCell-free DNA offers early warning for bloodstream infections in kids with leukemia
Researchers show that microbial cell-free DNA sequencing can predict bloodstream infections in children with leukemia days before the symptoms appear. Plasma microbial cell-free DNA sequencing (mcfDNA-Seq) offer a potential approach to protecting vulnerable patients by allowing treatment to start before the patient gets sick.
-
NewsEnhanced inner ear tropism of Adeno-Associated Virus (AAV) vectors via peptide display on AAV1 capsid
Researchers improving efficiacy of AAV)-mediated gene therapy for the inner ear screened and inserted short peptide motifs onto the surface of the AAV1 capsid. These engineered vectors achieved markedly higher transduction rates in inner ear hair cells and supporting cells.
-
NewsCOVID-19 infection predicts higher risk of kidney disease, study finds
Researchers have found that previous COVID-19 infection is a significant risk factor for kidney disease. Compared to influenza, those with a history of COVID-19 infection have a 2.3-times higher risk of acute kidney injury and a 1.4-times higher risk of chronic kidney disease, according to an analysis of over three million patients.
-
NewsSingle daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens
A phase 3 clinical trial has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and lenacapavir (BIC/LEN) – may simplify treatment significantly for people with HIV who currently take very complex treatments.
-
NewsUrinary tract infections can trigger delirium and worsen dementia
Urinary tract infections can pose serious risks for older adults, particularly those with Alzheimer’s disease and other forms of dementia. In older patients, a common UTI can trigger delirium, a medical emergency marked by sudden confusion and altered awareness.
-
NewsNew study finds sex and menopause-based differences in presentation of early Lyme disease
In a new study, researchers found that male and female patients with early Lyme disease present with different signs of the disease in the symptoms they report, their physical exams and their laboratory test results.
-
NewsScientists find that silencing bacteria can worsen heart infections
By studying a bacterium responsible for a severe heart infection, the scientists show that disrupting bacterial communication can be associated with adverse clinical outcomes. These findings open the door to more targeted therapeutic strategies against this type of infection.
-
NewsResearchers engineer bacteria capable of consuming tumours from the inside out
A research team is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumours from the inside out. They added a gene to the organism from a related bacterium that can better tolerate oxygen and found a way to activate the oxygen-resistant gene at just the right time.
-
NewsFirst evidence of fungal pathogen becoming more deadly when co-infected with tuberculosis
Co-infection of Mycobacterium tuberculosis, together with Cryptococcus neoformans, is a grave public health concern, increasing the risk of death significantly. Researchers have found that in the presence of Mycobacteria, the fungus changed its cell density, cell diversity, and capsule size.
-
NewsComplexity key to preventing infection after heart surgery
Research indicates that uniform materials could be the culprit behind deadly infections that can occur when using synthetic materials for cardiovascular grafts.
-
NewsBooster jabs reduce the risks of COVID-19 deaths, study finds
Booster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England.
-
NewsNew antibody–drug conjugate strategy to block HIV infection
New antibody–drug conjugates (ADCs) combine a CD4 mimic with neutralizing antibodies for enhanced suppression of HIV infection. By targeting the gp120 on the viral envelope via a two-step mechanism, the ADCs effectively block viral entry.
-
NewsNew clinical guidelines to reduce central line-associated bloodstream infection
Central line-associated bloodstream infections remain a major challenge in ICUs. A team of clinicians has proposed updated guidelines to standardize the clinical practices addressing CLABSI, aiming to reduce infection rates and improve outcomes for critically ill patients.
-
NewsHPV cancer vaccine slows tumor growth, extends survival in preclinical model
Scientists discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to formulations that supercharge the immune system’s ability to attack HPV-driven tumors.
-
NewsStiff gels slow germs: New study maps hydrogel properties that control bacterial growth
Scientists has found that firmer, lower water content hydrogels limit bacterial growth, with implications for designing antibacterial coatings, infection models, and advanced medical materials.
-
NewsGenotype-specific response to 144-week entecavir therapy for HBeAg-positive chronic hepatitis B
HBV genotype B demonstrates superior histological responses to ETV therapy compared with genotype C, supporting the clinical value of HBV genotyping for personalized CHB management. These findings highlight the importance of considering viral genotype when evaluating treatment outcomes.
-
NewsResearchers identify strategies for preventing the most infectious strains of S. aureus in the NICU
A new study has identified which strains of Staphylococcus aureus – commonly known as staph – are commonly transmitted in neonatal intensive care units and which specific strains are most likely to cause invasive and serious infections.